Leadership & Pay ·
ANI Pharmaceuticals appointed Henry Gosebruch to its Board of Directors effective August 19, 2026, with an initial…
ANIPAni Pharmaceuticals Inc
ANI Pharmaceuticals appointed Henry Gosebruch to its Board of Directors effective August 19, 2026, with an initial restricted stock award valued at $525,000. Concurrently, Muthusamy "Samy" Shanmugam resigned as a director but will remain in his executive roles as Head of Research and Development and Chief Operating Officer of New Jersey Operations. The company operates in the biopharmaceutical industry, developing and commercializing therapeutics for rare diseases, generics, and branded products.